ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer

TerminatedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

January 3, 2025

Study Completion Date

March 14, 2025

Conditions
Prostate Cancer
Interventions
DEVICE

FocalOne

The objective of this study is to evaluate the clinical effectiveness and safety of treatment of prostate cancer in patients who have received a focal HIFU treatment using the Focal One medical device. This study is a non-interventional study. All the data will be collected from routine care. Data as indicated in the table below will be systematically recorded on the e-CRF to coincide with the scheduled follow-up visits at 3, 6 and 12 months.

Trial Locations (5)

33011

Hospital Universitario Central De Asturias, Oviedo

39008

Hospital Universitario Marqués De Valdecilla, Santander

46014

Hospital Consorcio General Universitario de Valencia, Valencia

21 11009

Hospital Universitario Puerta del Mar, Cadiz

46 28007

Hospital General Universitario Gregorio Marañón C/ Doctor Esquerdo, Madrid

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EDAP TMS S.A.

INDUSTRY